Prevalence of anti-HAV and anti-HEV antibodies in Konya, Turkey
dc.contributor.author | Atabek, ME | |
dc.contributor.author | Fyndyk, D | |
dc.contributor.author | Gulyuz, A | |
dc.contributor.author | Erkul, I | |
dc.date.accessioned | 2020-03-26T16:55:25Z | |
dc.date.available | 2020-03-26T16:55:25Z | |
dc.date.issued | 2004 | |
dc.department | Selçuk Üniversitesi | en_US |
dc.description.abstract | Objective: To determine the prevalence of antibodies to hepatitis A (HAV) and E (HEV) Viruses in the different areas of Konya. Methods: Anti-HAV and anti-HEV antibodies were investigated in 210 healthy children randomly selected (100 from rural areas and 110 from urban areas of Konya). None gave a history of previous icterus nor other signs of hepatitis, had received blood transfusion and HAV vaccine, or had been on hemodialysis. Results: Evidence of HAV infection Occurred in children under the age of 6 years. The seroprevalence rate was 67.8% in rural areas and 25.8% in urban areas. This increased rapidly with age and became universal after 11 years of age in both areas. In contrast, HEV infections were not detected until children were 6-11 year olds, and the 5.2% seroprevalence rate ill urban areas and 8.5% seroprevalence rate in rural areas in this age group did not significantly increase in older age group. The prevalence of anti-HAV as well as anti-HEV was significantly higher in children with poor socio-economic conditions in both areas. Conclusions: These results Suggest that HAV infection in rural areas of Konya is widespread and that environmental and socio-economic factors play a major role in its transmission. In contrast, hepatitis E is not a public health problem in Konya. (C) 2003 Elsevier Ireland Ltd. All rights reserved. | en_US |
dc.identifier.doi | 10.1016/S0168-8510(03)00123-4 | en_US |
dc.identifier.endpage | 269 | en_US |
dc.identifier.issn | 0168-8510 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 15036814 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 265 | en_US |
dc.identifier.uri | https://dx.doi.org/10.1016/S0168-8510(03)00123-4 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12395/19171 | |
dc.identifier.volume | 67 | en_US |
dc.identifier.wos | WOS:000220019600004 | en_US |
dc.identifier.wosquality | Q2 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | ELSEVIER SCI IRELAND LTD | en_US |
dc.relation.ispartof | HEALTH POLICY | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.selcuk | 20240510_oaig | en_US |
dc.subject | hepatitis A | en_US |
dc.subject | hepatitis E | en_US |
dc.subject | seroprevalence | en_US |
dc.subject | children | en_US |
dc.title | Prevalence of anti-HAV and anti-HEV antibodies in Konya, Turkey | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1
Yükleniyor...
- İsim:
- atabek2004 123.pdf
- Boyut:
- 57.7 KB
- Biçim:
- Adobe Portable Document Format
- Açıklama: